2025
SJR Q1
JCR Q1 · 14,3
OA
33 matched articles
SCIE
Journal detail
Journal of Experimental and Clinical Cancer Research
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0392907817569966
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 3,731
- Quartile Q1
- H-Index 152
- Cites/doc 11,75
- Docs (3y) 939
- Cites (3y) 12.196
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 14,3
- 5Y JIF 14,3
- JCI 2,72
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q1
- Oncology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 3,731 | 14,3 | 14,3 | 2,72 | Q1 | 152 |
| 2024 | Q1 | Q1 | 3,328 | 12,8 | 12,2 | 2,44 | Q1 | 136 |
| 2023 | Q1 | Q1 | 2,806 | 11,4 | 11,4 | 2,35 | Q1 | 136 |
| 2022 | Q1 | Q1 | 2,413 | 11,3 | 11,5 | 2,06 | Q1 | 136 |
| 2021 | Q1 | Q1 | 2,35 | 12,7 | 11,7 | 2 | Q1 | 136 |
| 2020 | Q1 | Q1 | 2,752 | 11,2 | 10 | 1,94 | Q1 | 136 |
| 2019 | Q1 | Q1 | 2,127 | 7,1 | 6,5 | 1,62 | Q1 | 136 |
| 2018 | — | Q1 | — | 5,6 | 5,1 | 1,43 | Q1 | — |
| 2017 | Q1 | Q1 | 2 | 6,2 | 5,3 | 1,43 | Q1 | 136 |
| 2016 | Q1 | Q1 | 1,612 | 5,2 | 4,6 | — | — | 136 |
| 2015 | Q1 | Q1 | 1,639 | 4,4 | 4,1 | — | — | 136 |
| 2014 | Q1 | Q1 | 1,653 | 4,4 | 3,7 | — | — | 136 |
| 2013 | Q1 | Q2 | 1,462 | 3,3 | 3,1 | — | — | 136 |
| 2012 | Q2 | Q2 | 1,149 | 3,1 | 2,7 | — | — | 136 |
| 2011 | Q2 | Q3 | 1,002 | 2,1 | 2 | — | — | 136 |
| 2010 | Q2 | Q3 | 0,826 | 1,9 | 1,5 | — | — | 136 |
| 2009 | — | Q4 | — | 1,3 | 1,3 | — | — | — |
| 2008 | — | Q4 | — | 1,2 | 1,1 | — | — | — |
| 2007 | — | Q4 | — | 1,5 | 1,2 | — | — | — |
| 2006 | — | Q4 | — | 0,9 | — | — | — | — |
| 2005 | — | Q4 | — | 0,7 | — | — | — | — |
| 2004 | — | Q4 | — | 0,6 | — | — | — | — |
| 2003 | — | Q4 | — | 0,6 | — | — | — | — |
| 2002 | — | Q4 | — | 0,7 | — | — | — | — |
| 2001 | — | Q4 | — | 0,8 | — | — | — | — |
| 2000 | — | Q4 | — | 0,5 | — | — | — | — |
| 1999 | — | Q4 | — | 0,5 | — | — | — | — |
| 1998 | — | Q4 | — | 0,3 | — | — | — | — |
| 1997 | — | Q4 | — | 0,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 23/333 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q1 | 23/328 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q1 | 25/322 |
| 2022 | ONCOLOGY | SCIE | Q1 | Q1 | 25/241 |
| 2021 | ONCOLOGY | SCIE | Q1 | Q1 | 24/245 |
| 2020 | ONCOLOGY | SCIE | Q1 | Q1 | 25/242 |
| 2019 | ONCOLOGY | SCIE | Q1 | Q1 | 33/244 |
| 2018 | ONCOLOGY | SCIE | Q1 | Q1 | 40/230 |
| 2017 | ONCOLOGY | SCIE | Q1 | Q1 | 34/223 |
| 2016 | ONCOLOGY | SCIE | Q1 | — | 42/217 |
| 2015 | ONCOLOGY | SCIE | Q1 | — | 50/213 |
| 2014 | ONCOLOGY | SCIE | Q1 | — | 43/211 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 76/203 |
| 2012 | ONCOLOGY | SCIE | Q2 | — | 80/197 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 115/196 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 122/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 130/166 |
| 2008 | ONCOLOGY | SCIE | Q4 | — | 128/143 |
| 2007 | ONCOLOGY | SCIE | Q4 | — | 102/132 |
| 2006 | ONCOLOGY | SCIE | Q4 | — | 120/127 |
| 2005 | ONCOLOGY | SCIE | Q4 | — | 119/123 |
| 2004 | ONCOLOGY | SCIE | Q4 | — | 116/123 |
| 2003 | ONCOLOGY | SCIE | Q4 | — | 111/120 |
| 2002 | ONCOLOGY | SCIE | Q4 | — | 101/114 |
| 2001 | ONCOLOGY | SCIE | Q4 | — | 90/107 |
| 2000 | ONCOLOGY | SCIE | Q4 | — | 97/103 |
| 1999 | ONCOLOGY | SCIE | Q4 | — | 96/105 |
| 1998 | ONCOLOGY | SCIE | Q4 | — | 98/104 |
| 1997 | ONCOLOGY | SCIE | Q4 | — | 95/102 |